Remove 2007 Remove Government Remove Manufacturing Remove Specialization
article thumbnail

MN Legislative Session 2025: Updates on Health Care Bills

Minnesota Academy of Family Physicians

The bill passed by a voice vote and was referred to the State and Local Government Committee. The Minnesota Council of Health Plans (MCHP) raised concerns, as the bill enacts new regulations on health plans, and they contend they have little control over pricing set by drug manufacturers. Read a summary of S.F. Read a summary of H.F.

article thumbnail

4th Circuit En Banc Judgment Affirms District Court Decision in Best Price Stacking Case

FDA Law Blog

47 (2007), which addressed the intent standard under the Fair Credit Reporting Act. The controversy over the FCA’s intent standard where the applicable statute or regulation is ambiguous has special relevance when the FCA is used to target inaccurate government price calculations. of America v. Burr , 551 U.S.

article thumbnail

Skinny Label and Induced Infringement: The Saga Continues

FDA Law Blog

government in the now-infamous (at least in FDA circles) Teva v. In the brief , the Government takes a strong position, stating “[t]he court of appeals’ holding that respondents presented sufficient evidence of petitioner’s intent to induce infringement is erroneous and warrants this Court’s review.” GSK skinny label case , the U.S.